Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	BecloClear Beclometasone dipropionate 500mcg/g equivalent to beclometasone dipropionate 50mcg per spray Nasal spray solution AFT Pharmaceuticals Limited Jewim Pharmaceutical (Shandong) Co., Limited, Shandong Province, China
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Jakavi Ruxolitinib phosphate 6.6mg equivalent to ruxolitinib 5mg Tablet Novartis New Zealand Limited Novartis Pharma Stein AG, Stein, Switzerland
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Jakavi Ruxolitinib phosphate 19.8mg equivalent to ruxolitinib 15mg Tablet Novartis New Zealand Limited Novartis Pharma Stein AG, Stein, Switzerland
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Jakavi Ruxolitinib phosphate 26.4mg equivalent to ruxolitinib 20mg Tablet Novartis New Zealand Limited Novartis Pharma Stein AG, Stein, Switzerland
Product: Active Ingredient: Dosage Form: New Zealand Sponsor: Manufacturer:	Montelukast Mylan Montelukast sodium 10.4mg equivalent to montelukast 10mg Film coated tablet Mylan New Zealand Limited Mylan Laboratories Limited, Maharashtra State, India

Dated this 27th day of November 2014.

CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Issue Number